GSK plugs into bioelectronics with $50 million venture fund
LONDON (Reuters) - GlaxoSmithKline raised its bet on using electrical signals in the body to target diseases on Thursday with the launch of a $50 mill...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/oG6JxWhlJYU/story01.htm
No comments:
Post a Comment